NASDAQ •
Healthcare •
Medical Devices •
Quote as of 09/04/2026
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization14.06 mln
Float4.30 mln
Earnings Date09/10/2026
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-4.97
Highly reliable
Relative Strength
99
/ 100
Top performer
Debt / Equity
17.42
Extremely leveraged
Pre-Tax Margin
-228,550%
Severely loss-making
ROE
-439
Deeply negative
Business Description
HeartSciences Inc. is a medical technology company based in Southlake, Texas, that uses artificial intelligence to make standard heart tests more informative and useful for doctors. Its main product, the MyoVista wavECG, is a resting ECG device that can detect early signs of heart dysfunction while also performing a routine heart tracing in a single test. The company also offers a cloud-based platform that allows its AI tools to work alongside a range of existing ECG hardware. Founded in 2007 and formerly known as Heart Test Laboratories Inc., HeartSciences aims to help identify heart disease earlier and more reliably than traditional methods allow.
